220 related articles for article (PubMed ID: 35702128)
1. Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer.
Lou C; Jin F; Zhao Q; Qi H
Am J Transl Res; 2022; 14(5):3240-3246. PubMed ID: 35702128
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.
Kusama H; Kittaka N; Soma A; Taniguchi A; Kanaoka H; Nakajima S; Oyama Y; Seto Y; Okuno J; Watanabe N; Matsui S; Nishio M; Fujisawa F; Honma K; Tamaki Y; Nakayama T
Breast Cancer; 2023 Nov; 30(6):1085-1093. PubMed ID: 37782377
[TBL] [Abstract][Full Text] [Related]
3. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
Pang J; Wang S; Liao L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
Yang N; Han X; Yu J; Shu W; Qiu F; Han J
J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
[TBL] [Abstract][Full Text] [Related]
5. Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
Wang C; Shi Q; Zhang G; Wu X; Yan W; Wan A; Xiong S; Yuan L; Tian H; Ma D; Jiang J; Qi X; Zhang Y
Oncologist; 2024 May; 29(5):e635-e642. PubMed ID: 38431781
[TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma.
Zhang T; Liu W; Xu C
Front Oncol; 2023; 13():1166802. PubMed ID: 37746281
[TBL] [Abstract][Full Text] [Related]
7. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Jia W; Yuan L; Ni H; Xu B; Zhao P
Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
[TBL] [Abstract][Full Text] [Related]
9. Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer.
Yang G; Liu P; Zheng L; Zeng J
Front Surg; 2022; 9():1004687. PubMed ID: 36406359
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis.
Nishio S; Murotani K; Yamagami W; Suzuki S; Nakai H; Kato K; Tokunaga H; Nomura H; Yokoyama Y; Takehara K; Okamoto A
Gynecol Oncol; 2024 Feb; 181():46-53. PubMed ID: 38113633
[TBL] [Abstract][Full Text] [Related]
11. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients.
Lusho S; Durando X; Mouret-Reynier MA; Kossai M; Lacrampe N; Molnar I; Penault-Llorca F; Radosevic-Robin N; Abrial C
Front Oncol; 2021; 11():678315. PubMed ID: 34367964
[TBL] [Abstract][Full Text] [Related]
12. Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes.
Kaytaz Tekyol K; Gurleyik G; Aktaş A; Aker F; Tanrikulu E; Tekyol D
Cureus; 2021 Apr; 13(4):e14774. PubMed ID: 34094739
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.
Chae S; Kang KM; Kim HJ; Kang E; Park SY; Kim JH; Kim SH; Kim SW; Kim EK
Curr Oncol; 2018 Apr; 25(2):e113-e119. PubMed ID: 29719435
[TBL] [Abstract][Full Text] [Related]
14. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.
Eren T; Karacin C; Ucar G; Ergun Y; Yazici O; İmamoglu Gİ; Ozdemir N
Medicine (Baltimore); 2020 May; 99(22):e20346. PubMed ID: 32481414
[TBL] [Abstract][Full Text] [Related]
15. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
Zhang D; Zeng H; Pan Y; Zhao Y; Wang X; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Chen M; Hu D
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556261
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of HALP score and combination of peripheral blood multiple indicators in patients with early breast cancer.
Zhao Z; Xu L
Front Oncol; 2023; 13():1253895. PubMed ID: 38188308
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
18. Prognostic implications of the peripheral platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer patients.
Jin X; Wang K; Shao X; Huang J
Gland Surg; 2022 Jun; 11(6):1057-1066. PubMed ID: 35800742
[TBL] [Abstract][Full Text] [Related]
19. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
20. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer.
Kim HY; Kim TH; Yoon HK; Lee A
J Breast Cancer; 2019 Sep; 22(3):425-438. PubMed ID: 31598342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
